Location permission needed for a better experience.
EN
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 2021 İstanbul Üniversitesi İstanbul Tıp Fakültesi ÜYTE Eğitim Merkezi Üremeye Yardımcı Tedavi Uygulamaları Eğitimi
  • 2018 Sağlık Bilimleri Üniversitesi İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi/Doçent doktor
  • 2018 İstanbul Üniversitesi ve Moleküler Biyoloji Genetik Bölümü Doktora Programı (devam ediyor
  • 2010 Dokuz Eylül Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum
  • 2005 Hacettepe Üniversitesi Tıp Fakültesi
EXPERIENCE
  • 2021 Acıbadem Sağlık Grubu
  • 2014 - 2021 Sağlık Bilimleri Üniversitesi İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi / Doçent Doktor
  • 2012 - 2014 Kütahya Duımlupınar Üniversitesi Evliya Çelebi Eğitim ve Araştırma Hastanesi / Uzman Doktor
  • 2010 - 2012 Kayseri Develi Devlet Hastanesi (devlet hizmet yükümlülüğü) / Uzman Doktor
  • 2005 - 2010 İzmir Dokuz Eylül Üniversitesi Kadın Hastalıkları ve Doğum ABD/Dr.Ar.Gör.
MEMBERSHIPS
  • ASRM Amerikan Üreme Tıbbı Derneği
  • Türk Jinekoloji ve Obstetrik Derneği İstanbul Şubesi
  • ESHRE Avrupa İnsan Üremesi ve Embriyoloji Derneği
  • T.S.R.M Üreme Sağlığı ve İnfertilite Derneği
  • Endometriozis ve Adenomyozis Derneği
  • WES Dünya Endometriozis Derneği
  • EEL Avrupa Endometriozis Ligi
PUBLICATIONS
  • Endometrial polyps: Is the predictions of spontaneous regression possible? Obstet Gynecol Sci. 2021 Jan;64(l):l 14-121. doi: 10.5468/ogs.20242. Epub 2020 Dec 16. Yüksel S, Tuna G, Goksever Çelik Fİ, Salman S
  • Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer? J Obstet. Gynaecol. Res. 2021 Feb;47(2):560-569. doi: 10.1 11 1/jog. 14560. Epub 2020 Nov 16. Çelik E. Yirgin IK. Goksever Çelik II, Engin G, Sözen 11, Ak N. Saip P, Önder S, Topuz S, Salihoglu YS.
  • Endometriozis: Cerrahi ve IVF dışında ne var? SRM Blast Üreme Sağlığı ve İnferti 1 ite Derneği Bülteni, Kasım 2021 Goksever Çelik H, Buyru
  • MicroRNA analysis of desidua derived mesenchymal stem cells from preeclampsia patients Placenta I15 (2021) 12 19. Simsek N. Benian A. Sevgin K, Ergun Y. Goksever Çelik H, Karahuseyinoglu H, Gunel T.
  • The effect of diagnostic hysteroscopy performed before fresh and frozen-thawed embryo transfer in IVF cycles on the reproductive outcomes J Türk Ger Gynecol Assoc. 2021 Aug 3 1 ;22(3):206-21 I. doi: 10.4274/jtgga.galenos, 2021.2020.0136. Epub 2021 Eserol F, Goksever Çelik H, Aytan AN, Çelik A, Çelik E, Buyru F, Bastu E.
  • Is There Any Possibility of Uterine Sarcoma, STUMP and Benign Myoma Variants in the Patients Operated for Myoma Uteri? J Exp Clin Med 2021; 38(4): 538-544 doi: 10.52142/omujecm.38.4.26. Topçu EG, Ülker V, Gündüz N, Goksever Çelik H.
  • Failure to detect viral RNA in follicular fluid aspirates from a SARS-CoV-2 positive woman Reprod Sci. 2021 Feb 22; 1-3. doi: 10.1007/s43032-021-00502-9. Demirci C. Tulek F. Goksever Çelik H, Dönmez E, Tüysüz G, Gokcan B.
  • Do Serum Hepassocin levels change in women with Polycystic Ovary Syndrome? Eur .1 Obstet Gynecol Reprod Biol. 2021; 267: 137-141. doi.org/10.1016/j. ejogrb.2021.10.034 Gencer FK, Yüksel S, Goksever Çelik H.
  • İnsan Hastalıklarında Endotel Fonksiyon ve Disfonksiyonunun Moleküler Mekanizmaları İKSSTD 2020;12(3):201-16 doi: 10.5222/iksstd.2020.61587. Goksever Celik H, Kucukkaya RD, Alkac IM, Gunel T.
  • Epidermal cyst of the clitoris mimicking cliteromegaly: A case report and review of the literature Turkiye Klinikleri J Case Rep. 2020;28(1):13-6. DoI: 10.5336/caserep.2019-70989. Topcu EG, Okumus ZG, Demirkaya E, Gunduz N, Goksever Celik H.
  • Does Fetal Fibronectin Predict the Delivery Route in Nulliparous Women at Postterm Induced by Dinoprostone? Gynecol Obstet Reprod Med 2020;26(2):83-87 DOI: http://dx.doi.org/10.21613/GORM.2018.880. Goksever Celik H, Celik E, Yildirim GY.
  • The prevalence of endometrioma and associated malignant transformation in women over 40 years of age Journal of Gynecology Obstetrics and Human Reproduction, 2020 May;49(5):101725. doi: 10.1016/j.jogoh.2020.101725. Oral E, Sozen I, Iludag S, Demirkiran F, Ilvan S, Oncul M, Goksever Celik H.
  • Fertility outcomes after preconceptional laparoscopic abdominal cerclage for second- trimester pregnancy losses Eur J Obstet Gynecol Reprod Biol. 2021 Feb;257:59-63. doi: 10.1016/j.ejogrb.2020.12.012. Epub 2020 Dec 10. Demirel C. Goksever Çelik H, Tulek F, Kucukdemir B, Gokalp D, Ergin T, Lembet A.
  • Is amniotic fluid analysis during the second trimester a predictor for the detection of preterm labor? Journal of Istanbul Faculty of Medicine 2020; 83(4): 309-314. DOI: 10.26650/IUITFD.2019.0093. Kocyigit Y, Goksever Celik H, Ozturk E, Simsek M.
  • The impact of a poor quality embryo on the implantation chance of a good quality one when transferred together: A study on double blastocyst transfers Journal of Gynecology Obstetrics and Human Reproduction 2020 Nov 5;101967. doi: 10.1016/j.jogoh.2020.101967. Demirel C, Goksever Celik H, Tulek F, Tuysuz G, Donmez E, Ergin T, Buyru F, Bastu E.
  • Serum betatrophin levels are significantly increased in obese patients compared to lean patients regardless to the presence of PCOS Gynecol Endocrinol. 2020 Aug;36(8):678-681. doi: 10.1080/09513590.2020.1725964. Keyif B, Goksever Celik H, Balci BK, Celebi MM, Ozaltin S, Takmaz O, Buyru F, Bastu E.
  • Serum betatrophin levels are significantly increased in obese patients compared to lean patients regardless to the presence of PCOS Gynecol Endocrinol. 2020 Aug;36(8):678-681. doi: 10.1080/09513590.2020.1725964. Keyif B, Goksever Celik H, Balci BK, Celebi MM, Ozaltin S, Takmaz O, Buyru F, Bastu E.
  • Deep Infiltrating Endometriosis: Pain Assessment after Laparoscopic Management Arch Gynecol Obstet. 2020 Jul;302(1):165-172. doi: 10.1007/s00404-020-05583-6. Epub 2020 May 23. Bastu E, Goksever Celik H, Ozaltin S, Takmaz O, Yasa C, Kocyigit Y, Tas S, Yozgatli D, Soylu M, Gurleyik D, Durbas A, Gorgen H, Gungor M, Buyru F.
  • Investigation of human paternal mitochondrial DNA transmission in ART babies whose fathers with male infertility European Journal of Obstetrics & Gynecology and Reproductive Biology, 2019 May;236:183-192. doi: 10.1016/j.ejogrb.2019.02.011. Epub 2019 Feb 20. Eker C, Goksever Celik H, Balci BK, Gunel T.
  • Abdominal wall endometriosis: A monocentric continuous series and review of the literature Journal of Endometriosis and Pelvic Pain Disorders, 2019;11(2):95?101, DOI: 10.1177/2284026519834465. Goksever Celik H, Karacan T, Kaya C, Uhri M, Savkli AO, Bahat PY, Altintas T, Usta T, Polat I, Gorgen H, Oral E.
  • Does endometriosis have an effect on the survival of women with synchronous endometrial and ovarian cancer? Journal of Endometriosis and Pelvic Pain Disorders, 2019; 11(4):185-193. Celik E, Goksever Celik H, Sozen H, Onder S, Baktiroglu M, Topuz S, Salihoglu YS.
  • Endometriozis ve Genetik TSRM Blast Üreme Sağlığı ve İnfertilite Derneği Bülteni, Ocak 2019 Goksever Celik H, Oral E.
  • Evaluation of the Patients with Abnormal Uterine Bleeding Based on PALM-COEIN Classification İstanbul Med J 2019; 20(5): 477-81. Oruc NI, Goksever Celik H, Gunduz N, Yildirim G.
  • Clinical and Genetic Investigation of Premature Ovarian Insufficiency Cases from Turkey Journal of Gynecology Obstetrics and Human Reproduction, 2019 Apr 23;48(10):817-23. doi: 10.1016/j.jogoh.2019.04.007. [Epub ahead of print] Oral E, Toksoy G, Sofiyeve N, Goksever Celik H, Karaman B, Basaran S, Azami A, Uyguner ZO.
  • Prediction of vaginal delivery with transperineal ultrasound in women induced with dinoprostone beyond 40 weeks of gestation Int J Reprod Contracept Obstet Gynecol. 2018 Aug;7(8): 2998-3003, DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20183290 Goksever Celik H, Celik E, Yildirim G.
  • Kanser ve Endotel Hücreleri Türkiye''de Lösemi Lenfoma Miyelom Araştırmaları Dergisi (LLM dergi), 2018;2(2):27-33, DOI:10.5578/llm.67089 Kucukkaya RD, Goksever Celik H, Alkac IM, Gunel T.
  • Evaluation of biochemical hyperandrogenism in adolescent girls with menstrual irregularities Journal of Medical Biochemistry, 2018; 37(1): 7-11; DOI: 10.1515/jomb-2017-0037 Goksever Celik H, Celik E, Polat I.
  • Do ovarian reserve markers predict the subsequent pregnancy outcomes in women with recurrent pregnancy loss? Turkish Journal of Biochemistry. 2018; 43(5): 481?486DOI: 10.1515/tjb-2017-0238 Yildirim GY, Goksever Celik H, Koroglu N, Karakus E.
  • Is there any risk for recurrence after the first operation of imperforate hymen? Clinical and Experimental Obstetrics and Gynecology, IROG.3971/36, doi number: 10.12891/ceog3971.2018, 2018; 2: 307-9. Goksever Celik H, Yildirim GY, Turkgeldi LS.
  • Is there any difference in between patients with primary endometriomas and recurrent endometriomas? Istanbul Medical Journal, 2018;19:147-51, DOI: 10.5152/imj.2017.27136. Goksever Celik H, Celik E, Turan G, Polat I.
  • Clinical predictors of successful vaginal myomectomy for prolapsed pedunculated uterine leiomyoma Journal of Turkish-German Gynecological Association, 2018;19:146-50, DOI: 10.4274/jtgga.2017.0135. Aydin S, Goksever Celik H, Marasli M, Bakar RZ.
  • Surgical Site Infections in a Tertiary Referral Obstetric and Gynecologic Clinic Center in Istanbul and Review of the Literature Gynecology Obstetrics and Reproductive Medicine, 2018;24(1): 37-41. DOI: 10.201613/GORM.2017.717 Goksever Celik H, Celik E, Dikmen S, Konal M, Gedikbasi A.
  • Do triple test results assess risk for adverse pregnancy outcomes? Şişli Etfal Tıp Bülteni, Ş.E.E.A.H. Tıp Bülteni 2017;51(2):119-24 Goksever Celik H, Celik E, Yildirim G.
  • Expression of von Willebrand factor and caldesmon in placental tissue in pregnancies complicated by intrauterine growth restriction Journal of Maternal-Fetal Neonatal Medicine, 2017 Nov 2:1-6; doi. 10.1080/14767058.2017.1395017. Goksever Celik H, Uhri M, Yildirim G.
  • Do triple test results predict risk for neonatal hyperbilirubinemia? Pakistan Journal of Medical Sciences, 2017; 33(4): 979-983; doi: https://doi.org/10.12669/pjms.334.12420. Goksever Celik H, Celik E, Yildirim G, Cetinkaya M.
  • Iniencephaly: a rare congenital anomaly reaching the term Case Reports in Perinatal Medicine, 2017 Sep; 6(2); DOI: 10.1515/crpm-2016-0056. Goksever Celik H, Semerci SY, Yildirim G, Cetinkaya M.
  • Diagnosis of placenta accreta with postpartum hemorrhage in the case of pregnancy termination Int J Reprod Contracept Obstet Gynecol. 2017 Dec;6(12):5619-5620. Goksever Celik H, Turan G, Ozdemir I.
  • Management of twin pregnancy with a hydatidiform mole and surviving healthy co-existent fetus Int J Reprod Contracept Obstet Gynecol. 2017 Dec;6(12):5636-5637. Goksever Celik H, Demirezen GM, Erdem B, Aydin AA; Ulker V.
  • Is blood transfusion necessary in all patients with disseminated intravascular coagulation associated postpartum hemorrhage? Journal of Maternal-Fetal Neonatal Medicine, 2017 Nov 7:1-5; doi. 10.1080/14767058.2017.1397125. Goksever Celik H, Celik E, Ozdemir I, Savkli AO, Sanli K, Gorgen H.
  • Different surgical techniques in tubo-ovarian abscess management Gynecology Obstetrics and Reproductive Medicine, 2017;23(1):32-36. Goksever Celik H, Celik E, Yuksel S, Bastu E, Ark HC.
  • Different Management Options for Tubo-Ovarian Abscess: A Tertiary Referral Center Experience Ok Meydanı Tıp Dergisi, 2017, 33(2):87-92. Goksever Celik H, Celik E, Yasa C, Yuksel S, Celik S, Dural O, Ark HC.
  • Risk factors for surgical site infection after hysterectomy Journal of Infections in Developing Countries, 2017; 11(4):355-360. Goksever Celik H, Celik E, Turan G, Seckin KD, Gedikbasi A.
  • Concomitant gynecological pathologies and risk factors for Adenomyosis Okmeydanı Tıp Dergisi 2016; 32(2):88-91 Seckin KD, Yucel B, Karsli MF, Soydar A, Goksever Celik H, Kiyak H, Kocbiyik A, Yildirim G.
  • Unruptured ectopic live pregnancy at 11 weeks gestation Istanbul Medical Journal, 2016; 17:111-13. Goksever Celik H, Bestel A, Celik E, Yildirim G.
  • Why do multiparous women with a history of vaginal delivery give birth by cesarean section? J Turk Ger Gynecol Assoc 2016; 17: 209-13. Goksever Celik H, Bestel A, Celik E, Aydin AA.
  • Uterin Kitleyle İlişkili Spontan Uterin Rüptüre Bağlı Hemoperitonyum Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 2015; Suppl.1: 18. Goksever Celik H, Celik E, Gunduz OD.
  • Hypertriglyceridemia-induced Acute Pancreatitis During Pregnancy Türkiye Klinikleri Jinekoloji Obstetrik Dergisi, DOI: 10.5336/gynobstet.2015-48356, 2018;28(1):26-9. Goksever Celik H, Celik E, Dikmen S, Aydin AA.
  • Basal cell carcinoma of the vulva: A case report Eur J Med Sci. 2015 Mar; 2(1): 26-29 Kocak C, Metineren MH, Goksever Celik H, Namdar ND.
  • Reply of the authors Fertility Sterility 2013;99(1):e2. Goksever Celik H, Dogan E.
  • Effect of laparoscopic excision of endometriomas on ovarian reserve: serial changes in the serum antimüllerian hormone levels Fertility Sterility 2012;97:14721478. Goksever Celik H, Dogan E, Okyay E, Ulukus C, Saatli B, Uysal S, Koyuncuoglu M.
  • Ovarian pregnancy Türkiye Klinikleri Jinekoloji Obstetrik Dergisi 2012;22(3):184-187 Goksever Celik H, Okyay RE, Soysal D, Koyuncuoglu M.
  • Primary pelvic hydatid cyst Türkiye Klinikleri Jinekoloji Obstetrik Dergisi 2010;20(1):53-56 Goksever H, Celiloglu M.
  • Angiomyxoma : A rare tumor of the umblical cord J Turkish-German Gynecol Assoc 2010; 11: 58-60. Goksever H, Celiloglu M, Kupelioglu A.
  • Kadınlarda kronik kasık ağrısı Klinik Aktüel Tıp Jinekoloji ve Obstetri Forumu 2010; 2(1): 30-37. Celiloglu M, Goksever H.
  • Hormon profili ile perimenopozal semptomlar arasindaki ilişki İstanbul Tıp Fakültesi Dergisi 2010; 73(4):92-96. Goksever H, Erata Y.
  • Üçlü tarama testi sonuçlarıyla gebelik komplikasyonları arasındaki ilişki Türkiye Klinikleri Jinekoloji Obstetrik Dergisi 2009;19(6):335-341. Goksever H, Erata Y, Kilic B.
  • Rektus abdominis kasında endometriyozis, olgu sunumu Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi 2008; 22(2):79-82. Goksever H, Dogan E, Dagdelen M, Tunk CO.
  • Preterm doğumlarda epidemiyolojik faktörler Türkiye Klinikleri Jinekoloji Obstetrik Dergisi 2008;18(5):294-305. Goksever H, Kilic B, Erata Y.
  • The evaluation of the internet and computer utilization by the fourth grade medical students Saudi Med j 2005; 26(12). Yıldız AN, Kılıç C, Bayhan GI, Goksever H, Karaarslan O.

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP
How can we help you?